ADL
AZN icon

Asset Dedication LLC’s AstraZeneca AZN Stock Holding History

Asset Dedication LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Sell
1,244
-129
-9% -$24.3K 0.01% 305
2026
Q1 		$271K Sell
1,373
-102
-7% -$19.7K 0.02% 278
2025
Q4 		$271K Sell
1,475
-81
-5% -$14.2K 0.02% 272
2025
Q3 		$239K Buy
1,556
+55
+4% +$8.32K 0.02% 310
2025
Q2 		$210K Sell
1,501
-48
-3% -$6.73K 0.02% 317
2025
Q1 		$228K Buy
1,549
+19
+1% +$2.75K 0.02% 280
2024
Q4 		$200K Buy
1,530
+68
+5% +$9.52K 0.02% 302
2024
Q3 		$228K Buy
1,462
+187
+15% +$30.2K 0.02% 310
2024
Q2 		$199K Sell
1,275
-16
-1% -$2.41K 0.01% 318
2024
Q1 		$166K Buy
1,291
+75
+6% +$9.93K 0.01% 315
2023
Q4 		$155K Buy
+1,216
New +$158K 0.01% 321
2020
Q1 		– Sell
-83
Closed -$8K – 650
2019
Q4 		$8K Buy
+83
New +$7.81K ﹤0.01% 483

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Asset Dedication LLC's AZN Position: Q2 2026 in Review

Asset Dedication LLC reduced its AstraZeneca (AZN) stake by 9.4% in Q2 2026, selling an estimated $24.3K and leaving 1,244 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #305.

Asset Dedication LLC first reported a position in AZN in Q4 2019 and has held it in 12 quarters since. The position peaked at $271K in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Asset Dedication LLC held 1,244 shares of AstraZeneca worth $236K as of Q2 2026.
  • Asset Dedication LLC sold 129 AstraZeneca shares in Q2 2026, an estimated $24.3K.
  • AstraZeneca made up 0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #305 holding.
  • Asset Dedication LLC first reported a position in AstraZeneca in Q4 2019 and has held it in 12 quarters since.
  • Asset Dedication LLC's AstraZeneca position peaked at $271K in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.